is it safe to switch from tirzepatide to semaglutide Switching semaglutide switch to tirzepatide Safely

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Maryland, USA Edwards K, Li X, Lingvay I (2022) Clinical and safety outcomes with GLP-1 receptor agonists and SGLT2 inhibitors in type 1 diabetes: a real-world study

GLP-1s blueprint was finally decoded: it was not an independent molecule, but a fragment snipped from a larger protein called proglucagon

This mode of regulation may enable interpretation and communication of extra-germline environmental cues, and thus optimize germ cell proliferation and progeny generation in ephemeral habitats and in pathophysiological conditions

And all benefit from consistent, proper refrigeration

Telogen effluvium is typically temporary

doi: 10.1016/S2213-8587(17)30412-6 118 MarsicoFPaolilloSGargiuloPBruzzeseDDell'AversanaSEspositoIet al